Fr

Canadian-made vaccines are in development, utilizing new genetic technology

Vancouver-based nanomedicine company Precision NanoSystems Incorporated (PNI) is developing a vaccine in the same class as the Pfizer and Moderna vaccines.
By: Heather Marie Connors
January 20, 2021
Photo by ARLEN REDEKOP /PNG
Photo by ARLEN REDEKOP /PNG

The vaccine being developed in Vancouver by PNI utilizes mRNA, meaning it is a class of vaccine that carries genetic instructions to trigger the body’s immune system to produce antibodies that can fight against SARS-CoV-2.

The project is still in a pre-clinical stage, but Canadian vaccine development such as this helps with future pandemic preparedness, building capacity and capability here at home. The federal government has invested $18.2 million to fund the vaccine through to clinical trials.

Government investment has also been made in Medicago, a Quebec City company currently developing a plant-based vaccine, as well as a large-scale production facility.

Many top pharmaceutical companies were looking into mRNA vaccine efficacy before the arrival of COVID-19. The advantage of mRNA medicines is they are fully synthetic and can be produced in laboratories in large amounts. They also can be more effective than traditional vaccines because they produce both antibodies and immune killer cells.

Source: Vancouver Sun

Related

What if you could eat the cure?
8 months ago

What if you could eat the cure?

A University of Ottawa plant biologist and a senior scientist at The Ottawa Hospital are researching a plant-based, edible vaccine for the novel coronavirus.
Ontario ice cream company to provide freezers for vaccine storage
2 months ago

Ontario ice cream company to provide freezers for vaccine storage

The Chapman family in Markdale, Ontario signed on to Canada’s pandemic response plan in the 1980s. Ready to do their part, the family-owned Chapman’s Ice Cream will become a cold storage facility for the Pfizer-BioNTech vaccine.
New biobank at University of Toronto will support wide range of COVID-19 research
3 months ago

New biobank at University of Toronto will support wide range of COVID-19 research

The biobank, led by a team from SickKids hospital, will securely house and collect biologic samples from across Toronto and make it easier for researchers to conduct studies on the virus.